{
  "meta": {
    "title": "18_Sedatives_And_Hypnotics",
    "url": "https://brainandscalpel.vercel.app/18-sedatives-and-hypnotics-dae4222a.html",
    "scrapedAt": "2025-11-30T12:34:09.454Z"
  },
  "questions": [
    {
      "text": "Which of the following is a benzodiazepine?",
      "choices": [
        {
          "id": 1,
          "text": "Flurazepam"
        },
        {
          "id": 2,
          "text": "Flumazenil"
        },
        {
          "id": 3,
          "text": "Amobarbital"
        },
        {
          "id": 4,
          "text": "Zaleplon"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Flurazepam</strong> is a<strong>&nbsp;benzodiazepine.</strong></p><table>\n<tbody>\n<tr>\n<td><strong>Class of drugs</strong></td>\n<td><strong>Mechanism of action</strong></td>\n<td><strong>&nbsp;Examples</strong></td>\n</tr>\n<tr>\n<td><strong>Benzodiazepines</strong></td>\n<td>Facilitate the action of GABA by <strong>increasing</strong> the <strong>frequency</strong> of<strong> opening</strong> of GABA mediated chloride channel&nbsp;</td>\n<td>\n<ul>\n<li>Alprazolam</li>\n<li>Clonazepam</li>\n<li>Lorazepam</li>\n<li>Midazolam</li>\n<li>Oxazepam</li>\n<li>Temazepam</li>\n<li>Estazolam</li>\n<li>Flurazepam</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Barbiturates</strong></td>\n<td>Facilitate the action of GABA by <strong>increasing</strong> the <strong>opening duration</strong>&nbsp;of GABA mediated chloride channel&nbsp;</td>\n<td>\n<ul>\n<li>Amobarbital</li>\n<li>Phenobarbital</li>\n<li>Butabarbital</li>\n<li>Pentobarbital</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Z drugs</td>\n<td>Act like benzodiazepines</td>\n<td>\n<ul>\n<li>Zaleplon</li>\n<li>Zolpidem</li>\n<li>Zopiclone</li>\n<li>Eszopiclone</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Melatonin receptor agonists</td>\n<td>Activates MT<sub>1</sub> and MT<sub>2</sub> receptors</td>\n<td>\n<ul>\n<li>Ramelteon</li>\n<li>Tasimelteon</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Orexin antagonist</td>\n<td>Blocks orexins, neuropeptides that promote wakefulness</td>\n<td>\n<ul>\n<li>Suvorexant</li>\n<li>Daridorexant</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>5HT receptor agonist</td>\n<td>Affinity for 5HT &gt; D<sub>2</sub> receptor</td>\n<td>\n<ul>\n<li>Buspirone</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB4551",
      "difficulty": "easy"
    },
    {
      "text": "A  physician prescribes clonazepam to a patient with generalized anxiety disorder. Choose the false statement regarding its mechanism of action.",
      "choices": [
        {
          "id": 1,
          "text": "Bind at the α/γ interface of GABA-A receptor"
        },
        {
          "id": 2,
          "text": "Increase the affinity of the GABA-A receptor for GABA"
        },
        {
          "id": 3,
          "text": "Activate GABA-A receptors directly opening the Cl channel"
        },
        {
          "id": 4,
          "text": "Increase the frequency of opening of GABA receptor Cl channel"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Clonazepam is a <strong>benzodiazepine.</strong>&nbsp;These are <strong>allosteric </strong>modulators of the <strong>GABA<sub>A</sub> receptor.</strong> They&nbsp;do not directly activate GABA<sub>A</sub> receptors to open the Cl<sup>-</sup> channel.</p>\n<p>GABA<sub>A</sub> receptor<strong>&nbsp;</strong>is a transmembrane inhibitory receptor in the CNS that functions as a chloride ion channel and has 5 subunits.&nbsp;</p>\n<p>Benzodiazepines are allosteric modulators of the GABA<sub>A</sub> receptor that bind at the <strong>&alpha;/&gamma; interface</strong> of the receptor. This <strong>increases</strong>&nbsp;the <strong>affinity</strong> of the GABA<sub>A</sub> receptor for <strong>GABA</strong> thus&nbsp;<strong>increasing</strong> the<strong> frequency</strong> of the <strong>opening</strong> of the <strong>channel.</strong></p>\n<p>Barbiturates, on the other hand, have a different binding site to the receptor and they increase the duration of the GABA gated chloride channel opening.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB4543",
      "difficulty": "medium"
    },
    {
      "text": "Which is the shortest acting benzodiazepine?",
      "choices": [
        {
          "id": 1,
          "text": "Remimazolam"
        },
        {
          "id": 2,
          "text": "Midazolam"
        },
        {
          "id": 3,
          "text": "Lorazepam"
        },
        {
          "id": 4,
          "text": "Temazepam"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Remimazolam&nbsp;</strong>is the <strong>shortest-acting </strong>benzodiazepine<strong>. </strong>Its <strong>half-life</strong><strong>&nbsp;</strong>is just around<strong>&nbsp;37-53 mins.</strong></p>\n<p>Classification of benzodiazepines:</p>\n<ul>\n<li><strong>Long-acting:</strong> <br />\n<ul>\n<li>Flurazepam</li>\n<li>Diazepam</li>\n<li>Quazepam</li>\n<li>Chlordiazepoxide</li>\n</ul>\n</li>\n<li><strong>Intermediate-acting:</strong> <br />\n<ul>\n<li>Alprazolam</li>\n<li>Temazepam</li>\n<li>Lorazepam</li>\n</ul>\n</li>\n<li><strong>Short-acting:</strong> <br />\n<ul>\n<li>Triazolam</li>\n<li>Midazolam</li>\n</ul>\n</li>\n<li><strong>Ultra-short</strong> acting\n<ul>\n<li>Remimazolam</li>\n</ul>\n</li>\n</ul>\n<p>Note:&nbsp;Remimazolam was approved by FDA in 2020.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB4547",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following does not act via GABA potentiation?",
      "choices": [
        {
          "id": 1,
          "text": "Zopiclone"
        },
        {
          "id": 2,
          "text": "Midazolam"
        },
        {
          "id": 3,
          "text": "Thiopentone"
        },
        {
          "id": 4,
          "text": "Promethazine"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Promethazine </strong>does not act via GABA potentiation.<strong>&nbsp;</strong>It&nbsp;is a first-generation<strong> H<sub>1</sub>&nbsp;receptor antagonist.</strong></p>\n<p>Zopiclone, midazolam, and thiopentone act via GABA potentiation.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB5297",
      "difficulty": "medium"
    },
    {
      "text": "A patient diagnosed with insomnia is taking a drug belonging to the Z-compounds family. Which of the following does not belong to this family?",
      "choices": [
        {
          "id": 1,
          "text": "Zopiclone"
        },
        {
          "id": 2,
          "text": "Zaleplon"
        },
        {
          "id": 3,
          "text": "Zonisamide"
        },
        {
          "id": 4,
          "text": "Eszopiclone"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Zonisamide</strong> is a <strong>sulfonamide anticonvulsant</strong> drug, that has no activity on GABA receptors. It does not belong to the Z-compound drugs.<strong> </strong>It is an adjunct drug for Parkinson's disease, partial-onset seizures, infantile spasm, mixed seizure types of Lennox–Gastaut syndrome, myoclonic and generalized tonic-clonic seizure.</p>\n<p><strong>Z compounds</strong> are <strong>benzodiazepine receptor agonists</strong>. They have less anticonvulsant and muscle relaxant properties when compared to benzodiazepines.</p>\n<p>They are used for the treatment of insomnia. They include:</p>\n<ul>\n<li>Zolpidem</li>\n<li>Zaleplon</li>\n<li>Zopiclone</li>\n<li>Eszopiclone</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB5292",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following agents does not bind to GABA receptor chloride channel complex?",
      "choices": [
        {
          "id": 1,
          "text": "Ethanol"
        },
        {
          "id": 2,
          "text": "Alphaxolone"
        },
        {
          "id": 3,
          "text": "Zolpidem"
        },
        {
          "id": 4,
          "text": "Buspirone"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Buspirone</strong> does not bind to the GABA receptor chloride channel complex. It is a <strong>partial agonist</strong>&nbsp;at&nbsp;<strong>5-HT<sub>1A&nbsp;</sub>receptor&nbsp;</strong>used in the treatment of <strong>anxiety</strong>.</p>\n<p>Option A:<strong>&nbsp;</strong>Ethanol releases GABA and also has a binding site on the GABA receptor chloride channel complex.&nbsp;</p>\n<p>Option B:<strong>&nbsp;</strong>Alphaxolone is a neurosteroid and it acts through activation of GABA<sub>A</sub> receptors. These receptors are BZD insensitive.</p>\n<p>Option C:<strong>&nbsp;</strong>Zolpidem belongs to novel benzodiazepine receptor agonists called Z compounds. It binds to the BZD receptor present on the GABA receptor chloride channel complex.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB5290",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is an inverse agonist at the benzodiazepine receptor?",
      "choices": [
        {
          "id": 1,
          "text": "Phenobarbitone"
        },
        {
          "id": 2,
          "text": "Beta-carboline"
        },
        {
          "id": 3,
          "text": "Flumazenil"
        },
        {
          "id": 4,
          "text": "Picrotoxin"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The <strong>inverse agonist </strong>at&nbsp;the benzodiazepine receptor&nbsp;is <strong>beta-carboline.&nbsp;&nbsp;</strong></p>\n<p>It <strong>impedes</strong> the action of <strong>GABA</strong> and can cause <strong>anxiogenic, convulsive,</strong> and <strong>memory-enhancing</strong> effects.</p>\n<p>Option A:<strong>&nbsp;</strong>Barbiturates (phenobarbitone) are agonists at an allosteric site on the GABA<sub>A</sub> receptor that facilitate the action of GABA.</p>\n<p>Option C:<strong>&nbsp;Flumazenil</strong> is a <strong>competitive antagonist</strong> at the <strong>benzodiazepine</strong> receptor.</p>\n<p>Option D: Picrotoxin blocks Cl<sup>-</sup> channel non-competitively.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB5309",
      "difficulty": "medium"
    },
    {
      "text": "A 33-year-old woman with suspected diazepam overdose was administered the antidote for benzodiazepine poisoning. Which of the following statements is false about this antidote?",
      "choices": [
        {
          "id": 1,
          "text": "It is a specific antagonist of benzodiazepines"
        },
        {
          "id": 2,
          "text": "It may be used to treat barbiturate poisoning"
        },
        {
          "id": 3,
          "text": "It is administered intravenously"
        },
        {
          "id": 4,
          "text": "It acts at the same site on GABA channel where benzodiazepines bind"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Flumazenil </strong>is the antidote used in <strong>benzodiazepine</strong> poisoning. It is&nbsp;<strong>not used</strong> to treat <strong>barbiturate</strong> poisoning<strong>.&nbsp;</strong></p>\n<p>Flumazenil is a benzodiazepine (<strong>BZD</strong>) <strong>receptor-specific antagonist.&nbsp;</strong>It has no affinity for barbiturate binding sites on the GABA receptor Cl<sup>-</sup> channel complex.&nbsp;Flumazenil <strong>competes</strong> with BZD agonists and inverse agonists for the BZD receptors.&nbsp;</p>\n<p>Flumazenil is available only for <strong>intravenous use</strong>. It is used to treat benzodiazepine overdose and for the <strong>reversal</strong> of <strong>sedative effects</strong> produced by benzodiazepines administered during <strong>general anesthesia.</strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB5300",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following is a competitive antagonist of GABA at the GABA-A receptor?",
      "choices": [
        {
          "id": 1,
          "text": "Flumazenil"
        },
        {
          "id": 2,
          "text": "Picrotoxin"
        },
        {
          "id": 3,
          "text": "Bicuculline"
        },
        {
          "id": 4,
          "text": "Propofol"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Bicuculline </strong>is a <strong>competitive antagonist of GABA </strong>at the GABA-A receptor.<strong>&nbsp;</strong></p>\n<p>Option A: Flumazenil is a competitive antagonist at the alpha/gamma interface of the benzodiazepine site. This is different from the binding site of GABA which is the alpha/beta interface.</p>\n<p>Option B: Picrotoxin blocks Cl<sup>-</sup> channel non-competitively.</p>\n<p>Option D:&nbsp;Propofol is an agonist at the GABA-A receptor.</p>\n<p>Note: Muscimol is an agonist at the GABA-A receptor.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/cfdad2a8cad94ddf9b519680d61a080dx1280x1470.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB5316",
      "difficulty": "hard"
    },
    {
      "text": "In which of the following patients is the administration of barbiturates contraindicated?",
      "choices": [
        {
          "id": 1,
          "text": "29-year-old lady with history of anxiety disorder"
        },
        {
          "id": 2,
          "text": "33-year-old man with history of acute intermittent porphyria"
        },
        {
          "id": 3,
          "text": "50-year-old man with refractory status epilepticus"
        },
        {
          "id": 4,
          "text": "11-day-old neonate with kernicterus"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The administration of <strong>barbiturates</strong> is <strong>contraindicated</strong> in&nbsp;<strong>acute intermittent porphyria</strong>.</p>\n<p>The rate-limiting enzyme in porphyria synthesis is&nbsp;<strong>&delta;-aminolaevulinic acid</strong> (ALA)-<strong>synthetase</strong>. Barbiturates are <strong>enzyme inducers</strong> and they result in the increased synthesis of porphyrins and subsequent <strong>precipitation</strong> of acute intermittent <strong>porphyria.</strong></p>\n<p>Options A and C: Barbiturates are used to treat anxiety and refractory status epilepticus.</p>\n<p>Option D: Phenobarbitone can be used to treat kernicterus in newborns as it increases hepatic glucuronosyltransferase (UGT) enzyme activity and the conjugation of bilirubin.</p><hr><h3>Related Pearl: Drugs precipitating porphyria: \"BOOST CHAP\"</h3><p>The mnemonic \"<strong>BOOST CHAP</strong>\" can be used to remember the drugs precipitating porphyria.</p>\n<p><strong>B</strong>: Barbiturates</p>\n<p><strong>O</strong>: OCPs</p>\n<p><strong>O</strong>: Orphenadrine</p>\n<p><strong>S</strong>: Sulphonamides</p>\n<p><strong>T</strong>: Tetracyclines</p>\n<p><strong>C</strong>: Chloramphenicol, carbamazepine</p>\n<p><strong>H</strong>: Halothane, Hydralazine</p>\n<p><strong>A</strong>: Alcohol</p>\n<p><strong>P</strong>: Phenytoin</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB5296",
      "difficulty": "easy"
    },
    {
      "text": "A 28-year-old man with insomnia is prescribed a melatonin analog by his physician. Which of the following drugs would have been prescribed?",
      "choices": [
        {
          "id": 1,
          "text": "Doxepin"
        },
        {
          "id": 2,
          "text": "Suvorexant"
        },
        {
          "id": 3,
          "text": "Ramelteon"
        },
        {
          "id": 4,
          "text": "Trazodone"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Ramelteon</strong> is a<strong> melatonin analog&nbsp;</strong><span class=\"fontstyle0\">approved for the treatment of <strong>insomnia</strong>, particularly with <strong>difficulties</strong> of<strong> sleep onset</strong>.</span>&nbsp;</p>\n<p>It acts on both&nbsp;MT<sub>1</sub>&nbsp;and&nbsp;MT<sub>2</sub> receptors.&nbsp;</p>\n<ul>\n<li>MT<sub>1</sub> receptor - promotes the <strong>onset of sleep</strong> (hence used for induction of sleep)&nbsp;</li>\n<li>MT<sub>2</sub> receptor - shifts the timing of the <strong>circadian system</strong>.&nbsp;</li>\n</ul>\n<p>The other melatonin agonists are:</p>\n<ul>\n<li>Tasimelteon - used in insomnia in blind people</li>\n<li>Agomelatine - used in major depressive disorder</li>\n</ul>\n<p>Option A:<strong>&nbsp;</strong>Doxepin is a tricyclic antidepressant and functions as a serotonin-norepinephrine reuptake inhibitor. It is used in depression, anxiety, and some forms of insomnia.&nbsp;</p>\n<p>Option B:&nbsp;Suvorexant<strong>&nbsp;</strong>is a dual orexin receptor antagonist used in the treatment of insomnia.&nbsp;</p>\n<p>Option D:&nbsp;Trazodone<strong>&nbsp;</strong>is a mixed agonist and antagonist at various serotonin receptors used as an antidepressant and in alcohol dependence.&nbsp;&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB5317",
      "difficulty": "easy"
    },
    {
      "text": "A young woman, who is blind, presented with complaints of night-time insomnia. What is the drug of choice for her condition?",
      "choices": [
        {
          "id": 1,
          "text": "Agomelatine"
        },
        {
          "id": 2,
          "text": "Zolpidem"
        },
        {
          "id": 3,
          "text": "Tasimelteon"
        },
        {
          "id": 4,
          "text": "Ramelteon"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The drug of choice for <strong>insomnia</strong> in<strong> blind people</strong> is <strong>tasimelteon</strong>.&nbsp;<span class=\"fontstyle0\">It&nbsp;</span><span class=\"fontstyle2\">is a <strong>selective agonist</strong> of the <strong>melatonin</strong> (MT<sub>1</sub></span><span class=\"fontstyle2\">,&nbsp;</span><span class=\"fontstyle2\">MT<sub>2</sub></span><span class=\"fontstyle2\">)&nbsp;</span><span class=\"fontstyle2\">receptors. </span></p>\n<p><span class=\"fontstyle2\">Tasimelteon is approved for the treatment of <strong>non&ndash;24-h sleep-wake syndrome</strong> (nighttime insomnia and daytime sleepiness, alternating with asymptomatic periods) in totally <strong>blind patients</strong> experiencing <strong>circadian rhythm disorder</strong>.</span></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "ME9954",
      "difficulty": "medium"
    },
    {
      "text": "Your senior resident asks you to prescribe an orexin receptor inhibitor to a patient with insomnia. Which of the following drugs would you prescribe?",
      "choices": [
        {
          "id": 1,
          "text": "Suvorexant"
        },
        {
          "id": 2,
          "text": "Doxepin"
        },
        {
          "id": 3,
          "text": "Ritanserin"
        },
        {
          "id": 4,
          "text": "Agomelatine"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Suvorexant&nbsp;</strong>is an<strong> inhibitor </strong>of both&nbsp;<strong>orexin<sub>1</sub>&nbsp;</strong>and <strong>orexin<sub>2</sub></strong>&nbsp;<strong>receptors.</strong>&nbsp;It is approved for the treatment of <strong>insomnia.</strong>&nbsp;</p>\n<p>Orexins are produced in the lateral hypothalamus neurons and play a major role in maintaining the sleep cycle. Orexins promote wakefulness, while antagonists at orexin receptors enhance REM and non-REM sleep.</p>\n<div class=\"page\" title=\"Page 361\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Option B: Doxepin is a tricyclic antidepressant and has H<sub>1</sub> receptor antagonism effect. It is used for insomnia at lower doses.&nbsp;&nbsp;</p>\n</div>\n</div>\n</div>\n</div>\n<p>Option C: Ritanserin is a 5HT<sub>2A/2C</sub> receptor antagonist indicated in insomnia.</p>\n<p>Option D: Agomelatine is a melatonin receptor agonist and a 5HT<sub>2C</sub>&nbsp;receptor antagonist indicated in insomnia.&nbsp;</p><p><span data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Daridorexantis, an orexin receptor antagonist, is indicated for treating adult patients with insomnia characterized by difficulties with sleep onset and/or sleep maintenance. Because of its therapeutic target, the drug would not cause sleepiness in the morning&quot;}\" data-sheets-userformat=\"{&quot;2&quot;:33563519,&quot;3&quot;:{&quot;1&quot;:0},&quot;4&quot;:{&quot;1&quot;:2,&quot;2&quot;:6989903},&quot;5&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;6&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;7&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;8&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;9&quot;:0,&quot;11&quot;:4,&quot;12&quot;:0,&quot;16&quot;:10,&quot;28&quot;:1}\"><strong>Daridorexant</strong>, a dual orexin receptor antagonist, is indicated for treating adult patients with insomnia characterized by difficulties with sleep onset and/or sleep maintenance.</span></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC2189",
      "difficulty": "easy"
    },
    {
      "text": "A 68-year-old man with alcoholic liver disease is scheduled to undergo surgery. Which of the following benzodiazepines should be avoided in him?",
      "choices": [
        {
          "id": 1,
          "text": "Lorazepam"
        },
        {
          "id": 2,
          "text": "Oxazepam"
        },
        {
          "id": 3,
          "text": "Triazolam"
        },
        {
          "id": 4,
          "text": "Diazepam"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Diazepam </strong>and its long-acting metabolites can <strong>accumulate</strong> significantly in <strong>elderly</strong> patients with <strong>liver disease</strong> and therefore should<strong> not</strong> be used in such cases.</p>\n<p>Diazepam is a long-acting benzodiazepine. It is <strong>metabolized</strong> in the <strong>liver</strong> to active metabolites like nordazepam which are long-acting. Nordazepam is further converted to oxazepam which is conjugated with glucuronic acid to form inactive metabolites.</p>\n<p>Lorazepam, oxazepam, and triazolam are also metabolized in the liver but do not form long-acting active metabolites. As such, they can be used in elderly patients with liver disease but with caution.</p>\n<p>Oxazepam and lorazepam are intermediate-acting and undergo glucuronide conjugation directly to form inactive metabolites.</p>\n<p>Triazolam is a short acting benzodiazepine. It forms alpha-hydroxy active metabolites but they are short-acting and undergo glucuronide conjugation to form inactive metabolites.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB4549",
      "difficulty": "medium"
    }
  ]
}